Brain Insulin Signaling, Alzheimer Disease Pathology, and Cognitive Function. Issue 3 (27th July 2020)

• Record Type: Journal Article
• Authors: Arvanitakis, Zoe; Wang, Hoau‐Yan; Capuano, Ana W.; Khan, Amber; Taïb, Bouchra; Anokye‐Danso, Frederick; Schneider, Julie A.; Bennett, David A.; Ahima, Rexford S.; Arnold, Steven E.
• Is Part Of: Annals of neurology. Volume 88:Issue 3(2020)
• Page Start: 513
• Page End: 525
• Publication Date: 2020-07-27
• Subjects: Neurology -- Periodicals; Pediatric neurology -- Periodicals; Nervous system -- Surgery -- Periodicals; 616.8
• DOI: 10.1002/ana.25826
• Languages: English
• ISSNs: 0364-5134

Abstract

Abstract : Objective: To examine associations of molecular markers of brain insulin signaling with Alzheimer disease (AD) and cognition among older persons with or without diabetes. Methods: This clinical–pathologic study was derived from a community‐based cohort study, the Religious Orders Study. We studied 150 individuals (mean age at death =87 years, 48% women): 75 with and 75 without diabetes (matched by sex on age at death and education). Using enzyme‐linked immunosorbent assay, immunohistochemistry, and ex vivo stimulation of brain tissue with insulin, we assessed insulin signaling in the postmortem middle frontal gyrus cortex. Postmortem data documented AD neuropathology. Clinical evaluations documented cognitive function proximate to death, based on 17 neuropsychological tests. In adjusted regression analyses, we examined associations of brain insulin signaling with diabetes, AD, and level of cognition. Results: Brain insulin receptor substrate‐1 (IRS1) phosphorylation (pS 307 IRS1/total IRS1) and serine/threonine‐protein kinase (AKT) phosphorylation (pT 308 AKT1/total AKT1) were similar in persons with or without diabetes. AKT phosphorylation was associated with the global AD pathology score ( p = 0.001). In contrast, IRS1 phosphorylation was not associated with AD ( p = 0.536). No other associations of insulin signaling were found with the global AD score, including when using the ex vivo brain insulin stimulation method. In secondary analyses, normalized pT 308 AKT1 was positively correlated with both the amyloid burden and tau tangle density, and no other associations of brain insulin signaling with neuropathology were observed. Moreover, normalized pT 308 AKT1 was associated with a lower level of global cognitive function (estimate = −0.212, standard error = 0.097; p = 0.031). Interpretation: Brain AKT phosphorylation, a critical node in the signaling of insulin and other growth factors, is associated with AD neuropathology and lower cognitive function. ANN NEUROL 2020;88:513–525